○Shuri Hatakeyama1, Daisuke Ymamuro1, Masahiro Takahashi1, Toya Shimada1, Nanami Naruse1, Sota Yamaguchi1, Nanako Kagiyama1, Takako Kikuchi2, Akifumi Kushiyama1 (1. Meiji Pharm.Univ., 2. Inst. Med. Sci., Asahi Life Found)
Session information
Poster Presentation
(E) Pharmaceutical Health Care and Sciences
[31P-am] Pathophysiology
Sun. Mar 31, 2024 8:30 AM - 12:00 PM [Poster] Exhibition Hall AB (1F)
○Nanako Kagiyama1, Daisuke Yamamuro1, Masahiro Takahashi1, Toya Shimada1, Nanami Naruse1, Sota Yamaguchi1, Shuri Hatakeyama1, Takako Kikuchi2, Akifumi Kushiyama1 (1. Meiji Pharm.Univ., 2. Inst. Med. Sci., Asahi Life Found.)
○Touya Shimada1, Daisuke Yamamuro1, Masahiro Takahashi1, Nanami Naruse1, Nanako Kagiyama1, Shuri Hatakeyama1, Souta Yamaguchi1, Takako Kikuchi2, Akifumi Kushiyama1 (1. Meiji Pharm. Univ., 2. Inst. Med. Sci., Asahi Life Found.)
○Nanami Naruse1, Daisuke Yamamuro1, Masahiro Takahashi1, Touya Shimada1, Nanako Kagiyama1, Shuri Hatakeyama1, Souta Yamaguchi1, Noriaki Nagai2, Harumasa Yokota3, Taiji Nagaoka4, Akifumi Kushiyama1 (1. Meiji Pharm. Univ., 2. Kindai Univ., 3. Nihon Univ., 4. Asahikawa Med. Univ.)
○Sota Yamaguchi1, Nanami Naruse1, Daisuke Yamamuro1, Masahiro Takahashi1, Toya Shimada1, Nanako Kagiyama1, Shuri Hatakeyama1, Akifumi Kushiyama1 (1. Meiji Pharm.Univ)
○Takeshi Susukida1, Yuchen Sun2, Shigeki Aoki3, Kousei Ito3, Yoshihiro Hayakawa1 (1. Institute of Natural Medicine, Univ of Toyama, 2. Natl Inst Health Sci, 3. Grad School of Pharm Sci, Chiba Univ)
○Masaya Mori1, Ayako Shimada1, Risa Shiraki1, Kozue Nose1, Keiko Taniguchi2, Mitsugu Fujita3, Hiromi Ii1, Susumu Nakata1 (1. Lab. of Clinical Oncology, Kyoto Pharma. Univ, 2. Dept. of Drug Discovery Medicine, Kyoto Prefectural University of Medicine, 3. Faculty of Med, Kindai Univ)
○Rika Komoike1, Yuka Kondo1, Ayumi Tachikawa1, Maho Kondo1, Kosei Ito2, Hiromi Ii1, Susumu Nakata1 (1. Lab. of Clinical Oncology, Kyoto Pharma. Univ, 2. Graduate School of Biomedical Sciences, Nagasaki University)
[31P-am469S] Anti-cancer activity of a novel acetogenin analog in colorectal cancer xenograft models
○Natsuna Nishikawa1, Hiromi Ii1, Shota Ando1, Chiami Moyama1, Naoto Kojima2, Nakata Susumu1 (1. Lab. of Clinical Oncology, Kyoto Pharma. Univ, 2. Fac. Pharm. Sci., Nagasaki Int. Univ.)
○Maho Masuda1, Natsuki Tosa1, Masaya Mori1, Shota Ando1, Chiami Moyama1, Naoto Kojima2, Hiromi Ii1, Susumu Nakata1 (1. Lab. of Clinical Oncology, Kyoto Pharma. Univ, 2. Fac. Pharm. Sci., Nagasaki Int. Univ.)
○Teruna Fujino1, Kana Sakurai1, Kozue Nose1, Mitsugu Fujita2, Hiromi Ii1, Susumu Nakata1 (1. Lab. of Clinical Oncology, Kyoto Pharma. Univ, 2. Faculty of Med, Kindai Univ)
○Moe Sugiura1, Natsuna Yamamoto1, Ayaka Hashimoto1, Kozue Nose1, Mitsugu Fujita2, Hiromi Ii1, Susumu Nakata1 (1. Lab. of Clinical Oncology, Kyoto Pharma. Univ, 2. Faculty of Med, Kindai Univ )
○Taiki Abe1, Kanno Shin-ichiro2, Niihori Tetsuya1, Terao Miho3, Takada Shuji3, Aoki Yoko1 (1. Tohoku Univ. Sch. Med, 2. IDAC, 3. NCCHD)
○Tomoaki Hishida1,2, Yuriko Hishida1,2, Juan Carlos Izpisua Belmonte2,3 (1. Sch. Pharm. Sci., Wakayama-medical Univ., 2. Salk Institute, 3. Altos Lab)
○Seiji Miyauchi1, Shotaro Sasaki (1. Pharm. Sci., Toho Univ.)
○Naoto Tashiro1, Ayaka Miyano2, Shingo Ito1,2,3, Michihiko Sugimoto4, Kimi Araki5, Satohiro Nakao5, Naomi Nakagata5, Toru Takeo5, Takeshi Masuda6, Sumio Ohtsuki1,2,3 (1. Sch. Pharm., Kumamoto Univ., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ., 3. Fac. Life Sci., Kumamoto Univ., 4. RIKEN, 5. CARD., Kumamoto Univ, 6. Institute for Advanced Biosciences, Keio Univ.)
○Tomoya Yasujima1, Ayaka Kawamoto1, Takahiro Yamashiro1, Hiroaki Yuasa1 (1. Grad. Sch. Pharm. Sci., Nagoya City Univ.)
○Mione Yamasaki1, Mai Hirose1, Tomoya Yasujima1, Takahiro Yamashiro1, Hiroaki Yuasa1 (1. Grad. Sch. Pharm. Sci., NagoyaCity Univ.)
○Qiunan Zhu1, Hiroshi Arakawa1, Yoshiyuki Shirasaka1, Ikumi Tamai1 (1. Grad. Sch. Pharm. Sci., Kanazawa Univ.)
○Kohshi Kusumoto1, Kiyomi Sasaki2, Sota Hashimoto3, Reina Maki3, Hiroto Ohno3, Tokuyuki Yoshida2, Takao Inoue2, Keiichiro Okuhira1,3 (1. Grad. Sch. Pharm. Sci., Osaka Med. Pharm. Univ., 2. NIHS, 3. Osaka Med. Pharm. Univ.)
○Toshiki Kurosawa1, Natsuki Sawara1, Keito Shioda1, Rinka Inamura1, Ayaka Okubo1, Erika Takaura1, Hiroshi Ishikawa2, Yoshiyuki Kubo1, Yoshiharu Deguchi1 (1. Teikyo Univ., 2. Univ. of Tsukuba)
○Daiki Sako1, Toshiki Kurosawa1, Yoshiyuki Kubo1, Takeshi Hanada2, Daisuke Saigusa1, Sumio Ohtsuki3, Yoshiharu Deguchi1 (1. Fac. Pharma-Sci., Teikyo Univ., 2. Daiichi-Sankyo Co., Ltd., 3. Fac. Life Science., Kumamoto Univ.)
○Hiroto Kataoka1, Tetsuya Saita1 (1. Grad. Sch. Eng., Sojo Univ.)
○Hroshi Yuyama1, Tsubasa Yoshizato1, Hiroaki Shimada1, Atsushi Kawase1 (1. Pharm. Sci. Kinki Univ.)
○Chieri Fujino1, Satoshi Ueshima1, Toshiya Katsura1 (1. College of Pharm. Sci., Ritsumeikan Univ.)
○Yoshimi Hirenzaki1, Serina Okamoto1, Shugo Yamashita1, Shunsuke Kimura1, Akiko Kiriyama1 (1. Doshisha Women's College of Liberal Arts)
○Takeshi Goromaru1, Kazuki Hayashi1, Yuriko Fujii1, Takashi Ishizu1 (1. Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University)
○Yuna Hiramatsu1, Genki Minegishi1, Atsushi Miyajima1, Yasuhiro Kazuki2,3, Kaoru Kobayashi1 (1. Meiji Pharm.Univ., 2. Grad.Sch.of Med.,Tottori Univ., 3. Chrom. Engn. Res. Ctr., Tottori Univ.)
○Koki Kasai1, Takashi Yoshikado1, Yukana Tomoda1, Kenji Okada1, Mikako Oka1, Koji Chiba1 (1. Yokohama Univ. Pharm.)
○Keisuke Kiyomiya1, Ryuto Tomabechi4, Naoki Saito1, Kenta Watai1, Tappei Takada2, Yoshiyuki Shirasaka3, Hisanao Kishimoto1, Kei Higuchi1, Katsuhisa Inoue1 (1. Tokyo Univ. of Pharm. and Life Sci., 2. Tokyo Univ. Hos. pharm., 3. Faculty of Pharm., Inst. of Med., Pharm. and Health Sci. Kanazawa Univ., 4. Kitasato Univ.)
○Reo Kameoka1, Toshiyuki Kudo1,2, Yasuko Ogawa1, Yoshiaki Yamagishi1,2, Kiyomi Ito1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Inst. Pharm. Sci., Musashino Univ.)
○Shengyu Dai1, Tomoki Nakatsuji1, Yukio Kato1, Hiroshi Arakawa1 (1. Grad. Sch. Pharm. Sci., Kanazawa University)